3D Bioprinting Market Research Report: By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), By Material (Living Cells, Hydrogels, Extracellular Matrices), By Application (Research Applications, Clinical Applications), By End-user (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes) - Forecast till 2028
Get Free Sample of This Report at: https://www.marketresearchfuture.com/sample_request/869
3D bio printing’s significant applications include emergency dwellings, personal accessories, medical and testing devices, personal protective equipment (PPE), visualization aids, and more. The technology also provides training and visualization aid to healthcare professionals, which helps overcome the challenge of dearth of skilled personnel. Companies are competing with each other for a higher share in the market, by adopting strategies like new launches, agreements and partnerships. For instance, in August 2020, Isinnova, a reputed engineering firm in Italy, designed a 3D-printable mask connector known as Charlotte valve that connects Decathlon’s Easybreath snorkelling masks with CPAP machines.
Organ transplantation is another growth rendering factor in the global market, as it requires extensive use of the 3D bioprinting technology. Soaring incidences of various chronic diseases have also fostered the urgent need for effective organ and tissue transplants, which assists in market growth. Cost-effectiveness of 3D bioprinting combined with the escalating deployment of small prosthetics as well as implants for the treatment of dental or craniofacial disorders also add to the market value.
3D Bioprinting Market Segmental Analysis
The 3D bioprinting market has been considered for technology, material, application, and end-user.
Technologies analyzed in the report are microextrusion bioprinting, inkjet 3D bioprinting, magnetic 3D bioprinting and laser-assisted bioprinting. The inkjet 3D bioprinting market is growing relatively better than its counterparts and can continue to scale steadily during the given period.
Material-based market segments are hydrogels, living cells and extracellular matrices.
Top application areas of 3D bioprinting include research along with clinical applications.
End-users that are prominent in the global market for 3D bioprinting are research organizations & academic institutes along with pharmaceutical & biotechnology companies.
3D Bioprinting Market Regional Outlook
The regional distribution of the 3D bioprinting market covers Europe, the Middle East & Africa (MEA), Asia Pacific (APAC), as well as the Americas.
In 2017, the American market clinched the top position in view of the mounting use of 3D products, the burgeoning pool of additive manufacturers and the excellent financial condition of the patients. Moreover, the recent COVID-19 pandemic has bolstered the need to develop vaccine and has raised the focus on drug testing, which has made scientists extensively use the 3D bio-printing technology to conduct preclinical trials. Likewise, a number of biotherapeutic vendors in the region are utilizing the technology for conducting novel coronavirus-based researches. For instance, in August 2020, Viscient Biosciences had used the 3D bioprinting technology for the development of a lung tissue for conducting an exhaustive viral infectivity study. The company also explored a potential therapy that could work against the SARS-CoV-2 infection.
Asia Pacific could attain the fastest CAGR in the next couple of years, as a result of the fast-expanding healthcare sectors in China and India. Rising spending on R&D activities paired with the dramatic increase in mortality rate since the COVID-19 outbreak also push the market demand in the region. Lower number of organ donors also strengthen the 3D bioprinting market’s position in the region while the emerging popularity of the magnetic levitation technology for healthcare applications in human cell regeneration, toxicity screening and vascular muscle printing has led to significant business growth.
3D Bioprinting Market Key Companies
Affluent firms in the 3d bioprinting industry are REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), Regenovo Biotechnology Co. Ltd. (China), EnvisionTEC GmbH (Germany), Allevi (U.S.), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), FUJIFILM Wako Automation Corporation (U.S.), Cellink AB (Sweden), Organovo Holdings Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), Poietis (France), to mention a few.
Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Comments